MedTrace Logo

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

NCT00298337 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2006-10-18

No results posted yet for this study

Summary

The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants

Conditions

Interventions

DRUG

Mixture of probiotic bacteria and prebiotic oligosaccharide

Sponsors & Collaborators

  • University of Helsinki

    lead OTHER

Principal Investigators

  • Erkki Savilahti, Professor · Helsinki University Central Hospital, Hospital for Children and Adults, PO Box 281, 00029 HUS, Finland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
37 Weeks
Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-10-31
Completion
2007-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00298337 on ClinicalTrials.gov